03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Apo-Cabergoline* : | |
Type | Medicine Non Marketed |
Originator | Dostinex |
Agent | Promopharm |
Distributor | Promopharm |
Laboratory | Apotex |
Responsible Party | Apotex Inc |
Origin | Canada |
Manufacturer | Apotex Inc |
Manufacturing Type | G |
Origin | Canada |
ATC | G02CB03 |
Apo-Cabergoline* :
Apo-Cabergoline* :
Apo-Cabergoline* :
Apo-Cabergoline* :
Apo-Cabergoline* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Apo-Cabergoline* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very Common |
Aggressiveness | Not known |
Alopecia | Uncommon |
Angina pectoris | Not known |
Asthenia | Very Common |
Blackout (Blacked-out) | Uncommon |
Blood creatine phosphokinase increased | Not known |
Blood pressure decreased | Common |
Cardiac valve disease | Very Common |
Cephalea | Very Common |
Chest pain | Not known |
Constipation | Common |
Delusion | Not known |
Depression | Common |
Dizziness | Very Common |
Dyspepsia | Very Common |
Dyspnoea (dyspnea) | Uncommon |
Epigastralgia (Epigastric pain) | Rare |
Epistaxis (Nasal bleeding) | Uncommon |
Fatigue | Very Common |
Fibrosis | Uncommon |
Gastritis | Very Common |
Haemoglobin decreased | Uncommon |
Hallucination | Not known |
Hemianopia | Uncommon |
Hepatic function disorder | Not known |
Hot flush | Common |
Hypersensitivity reactions | Uncommon |
Hypersexuality | Not known |
Hypotension | Common |
Leg cramps | Uncommon |
Libido increased | Uncommon |
Liver function test abnormal | Not known |
Mastodynia | Common |
Nausea | Very Common |
Oedema | Uncommon |
Oedema peripheral | Uncommon |
Orthostatic hypotension | Common |
Palpitations | Uncommon |
Paraesthesia (paresthesia) | Uncommon |
Pathological gambling | Not known |
Pericardial effusion | Very Common |
Pericarditis | Very Common |
Pleural effusion | Uncommon |
Pleural fibrosis | Very rare |
Pleurisy (Pleuritis ) | Not known |
Psychotic disorders | Not known |
Pulmonary fibrosis | Uncommon |
Respiratory disorder | Not known |
Respiratory failure | Not known |
Skin Eruption | Uncommon |
Somnolence | Common |
Sudden onset of sleep | Not known |
Syncope | Uncommon |
Tremor | Not known |
Vertigo | Very Common |
Visual disturbance | Not known |
Vomiting | Common |
NB : Products With Same Indication |
Different Units By MoH Code
Apo-Cabergoline* MoH 9665 :
Form | Tablet |
Package Size | Box of 8 |
Strength | 0.5mg |
Storage Condition | 15-30°C protect from humidity & light |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 56818/1 |
Submission date | 23/04/2018 |
Registration Year | 03/10/2018 |
Pending Year | 13/08/2018 |
Pending Reason | Incomplete file |
Archived Date | 08/04/2022 |
Price Comparison
You have to register to view this info
Drop File